Treatment of Hodgkin lymphoma: a 50-year perspective

J Clin Oncol. 2014 Jan 20;32(3):163-8. doi: 10.1200/JCO.2013.53.1194.
No abstract available

Publication types

  • Historical Article

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / history
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Bleomycin / administration & dosage
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Europe / epidemiology
  • History, 20th Century
  • Hodgkin Disease / diagnosis*
  • Hodgkin Disease / history
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Mechlorethamine / administration & dosage
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Survival Rate
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Biomarkers, Tumor
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Etoposide
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • BEACOPP protocol
  • COPP-ABVD protocol
  • MOPP protocol